prevalence of vitamin d deficiency in different groups of chronic renal failure patients.

Clicks: 380
ID: 182924
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 56 articles by views in genome research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Purpose: To determine and compare the vitamin D status of different groups CKD patients on hemodialysis, peritoneal dialysis, or no renal replacement therapy and to evaluate the effect of vitamin D therapy. Patients and Methods: This pilot study enrolled 40 consecutive CKD patients (21 men, 19 women) divided into three groups: 15 CKD patients in 1,2,3,4 stage of the disease without renal replacement therapy (RRT); 10CKD patients on hemodialysis (HD) and 15 CKD patients on peritoneal dialysis (PD), ten of which were on vitamin D therapy. Vitamin D status was determined by serum 25-xydroxyvitamin D (25OHD). Results: Ninety percent of patients were in vitamin D deficiency/insufficiency; and only 4 patients (10.0%) reached 25OHD levels above 75nmol/L. The median 25OHD level was 31.15nmol/L (interquartile range: 16.67-48.33nmol/L).Tendency of worse vitamin D status in women than in men was observed. Higher 25OHD levels were found in pre-dialysis patients (median 44.81nmol/L, 25%-75% percentile 16.24-52.21nmol/L) and lower in HD (median 31.15nmol/L, 25%-75% percentile 13.04-64.45nmol/L) and PD patients (median 33.38nmol/L, 25%-75% percentile 23.15-48.49nmol/L), but the difference did not reach statistical significance. Better vitamin D status was found in the PD group of patients receiving vitamin D preparations (p<0.05). Conclusions: 25OHD deficiency/insufficiency is prevalent in renal failure patients with or without renal replacement therapy. It seems that vitamin D therapy improves the vitamin D status of PD patients. Further larger studies are needed to clarify the effect of specific type vitamin D therapy on serum 25OHD levels and clinical outcome in different groups of CKD patients.
Reference Key
galunska2015journalprevalence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Bistra T. Galunska;Daniela I. Gerova;Dobrin N. Paskalev;Rositza Y. Zorcheva;Valentin Ch. Ikonomov;Valentin Vladimirov;Dobrin A. Svinarov
Journal genome research
Year 2015
DOI
10.5272/jimab.2015213.887
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.